Skip to main content
LEEEF
OTC Life Sciences

CEO Discloses 12.2% Stake in Leef Brands Amidst Going Concern and New Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.179
Mkt Cap
$47.708M
52W Low
$0.104
52W High
$0.257
52W Position info
72% above low
Off High info
30% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

LEEEF sits 72% above its 52-week low of $0.104.

Summary

Leef Brands' CEO, Micah P. Anderson, has disclosed a 12.2% beneficial ownership stake, formalizing his significant commitment to the company as it addresses a going concern warning and secures new financing.


Key Events · Ownership and Investor Activity · LEEEF

  • CEO's Significant Ownership Disclosed

    Micah P. Anderson, the Chairman, CEO, and President, beneficially owns 32,407,566 common shares, representing 12.2% of the company's outstanding stock.

  • Timing Coincides with Critical Financial Disclosures

    This initial Schedule 13D filing is dated March 26, 2026, the same day the company filed its 10-K disclosing a "going concern" warning and announced new equity financing and debt restructuring.

  • Stake Primarily from Corporate Actions

    The majority of the CEO's ownership was accumulated through various corporate transactions, including acquisitions, debt conversions, and restricted stock unit settlements, with 177,599 shares acquired via open market purchases.


Analysis · LEEEF · Life Sciences

This initial Schedule 13D filing reveals that Micah P. Anderson, Chairman, CEO, and President of Leef Brands Inc., beneficially owns a substantial 12.2% of the company's common shares. The disclosure, made on the same day as the company's "going concern" warning and announcement of new equity financing, signals strong insider commitment and alignment of interests at a critical juncture for the company. While most shares were acquired through corporate transactions over time, the formal reporting of this significant stake by the top executive provides a vote of confidence as the company navigates its financial challenges and seeks to improve liquidity.

At the time of this filing, LEEEF was trading at $0.18 on OTC in the Life Sciences sector, with a market capitalization of approximately $47.7M. The 52-week trading range was $0.10 to $0.26. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LEEEF - Latest Insights

LEEEF
Jul 24, 2026, 4:26 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.19818
Real-time Price: $0.1929 info
Change: -$0.00528 (-3%) info
Market Cap: $58.903M info
LEEEF
Jul 08, 2026, 7:09 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.20414
Real-time Price: $0.1929 info
Change: -$0.01124 (-6%) info
Market Cap: $58.903M info
LEEEF
Jun 16, 2026, 7:34 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.1751
Real-time Price: $0.1929 info
Change: +$0.0178 (+10%) info
Market Cap: $58.903M info
LEEEF
Jun 02, 2026, 3:56 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.160
Real-time Price: $0.1929 info
Change: +$0.0329 (+21%) info
Market Cap: $58.903M info
LEEEF
May 06, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.162919
Real-time Price: $0.1929 info
Change: +$0.029981 (+18%) info
Market Cap: $58.903M info